Company profile

Since its inception in 1993, European Medical Contract Manufacturing (EMCM) has grown to a centre of excellence in developing and manufacturing sterile medicinal products in GMP and ISO accredited facilities, that cater to the markets of Biomaterials, Pharmaceuticals and Tissue Engineering specialties conforming to the standards of the USFDA, EMEA & ISO. Our focus lies on those products which have unique qualities, serve niche markets and where the skill and expertise of our organisation can make a difference to the lives of millions tomorrow.


EMCM has grown from a start-up to a mid-sized company that employs over 75 and operates in over 1500 m2 of GMP accredited classified areas (clean rooms), conforming to ISO & GMP standards for compliant manufacturing of medical products.
Using such qualified facilities EMCM produces a broad range of medical products offering complete custom made service and product packages: from product development, through regulatory affairs, purchasing, manufacturing, final packaging, warehousing and distribution in the capacity of a contract manufacturer.

For its own products, EMCM focuses on the identification of product possibilities, design of products, development of products and manufacturing processes. EMCM has available Bone cements for Hip and Knee Arthroplasty (C-Ment Line) & Vertebroplasty (Vebroplast) procedures. In addition, EMCM supplies medtech companies with a gelatin based, resorbable cement restrictor (C-Plug) . These products have been on the European market for over 10 years and are classified as Medical Devices and possess a valid CE mark.

In addition to medical devices, EMCM has in the last years been active in the development and production of its Tissue Product portfolio, which addresses needs in the orthopaedic, trauma, dermatological & tissue regenerative market segments. The Tissue portfolio is developed using human and animal derived tissue as its base material. Under this segment, EMCM develops human grafts and xenografts under the flagship eTiss and eColl product portfolios respectively. The eTiss group of products are human allografts, which are supplied under the directives of the Human Tissue guidelines. The eColl group of products are bovine/porcine derived materials which are developed and to be supplied as CE marked medical devices.

A variety of developments in the area of controlled drug delivery and peptide delivery mechanisms embedded in the aforementioned carriers are being developed. Please enquire to know more about the status and availability of the products.

EMCM cooperates with global companies as well as works with various European and national universities in research and developmental projects that are aimed at increasing the depth of our existing portfolios. We continuously look to enhance our existing products and expand their distribution in global markets through innovation and research. While a few of our prominent products are listed on this website, please contact us to know more details on our pipeline.